rs202247809
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PP2PP3_Moderate
The NM_014252.4(SLC25A15):c.847C>T(p.Leu283Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. L283L) has been classified as Likely benign.
Frequency
Consequence
NM_014252.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC25A15 | NM_014252.4 | c.847C>T | p.Leu283Phe | missense_variant | Exon 7 of 7 | ENST00000338625.9 | NP_055067.1 | |
| TPTE2P5 | NR_038258.1 | n.623-8884G>A | intron_variant | Intron 7 of 7 | ||||
| TPTE2P5 | NR_038259.1 | n.452-8884G>A | intron_variant | Intron 5 of 5 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251182 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460216Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726444 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: SLC25A15 c.847C>T (p.Leu283Phe) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251182 control chromosomes. c.847C>T has been reported in the literature in at least one compound heterozygous individual affected with Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome (e.g., Tessa_2009). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 4%-19% of normal activity (Tessa_2009). The following publication has been ascertained in the context of this evaluation (PMID: 19242930). ClinVar contains an entry for this variant (Variation ID: 38404). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at